@article{f91c59230ec7466c820cb9a9aa3fcc0f,
title = "Pros and cons of antithrombotic therapy in end-stage kidney disease: a 2019 update",
keywords = "anticoagulants, antiplatelets, dialysis, G5D chronic kidney disease, guidelines, LOW-MOLECULAR-WEIGHT, ATRIAL-FIBRILLATION PATIENTS, ACUTE MYOCARDIAL-INFARCTION, DUAL ANTIPLATELET THERAPY, HEMODIALYSIS-PATIENTS, RENAL-DISEASE, WARFARIN USE, UNFRACTIONATED HEPARIN, VENOUS THROMBOEMBOLISM, FOCUSED UPDATE",
author = "Alexandru Burlacu and Simonetta Genovesi and Alberto Ortiz and Christian Combe and Carlo Basile and Daniel Schneditz and {van der Sande}, Frank and Popa, {Grigore T.} and Cornel Morosanu and Adrian Covic and {ERA-EDTA EUDIAL Working Group}",
year = "2019",
month = jun,
doi = "10.1093/ndt/gfz040",
language = "English",
volume = "34",
pages = "923--933",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "6",
}